Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Zhang · SciRah

Researcher profile · Semantic Scholar

L. Zhang

Share profile

L. Zhang — researcher profile on SciRah

h-index: 8
Works: 13
Citations: 486

Most-cited papers

Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52‐week results from a Phase 3 double‐blind randomized, controlled trial
C. Bodemer, A. Kaszuba, K. Kingo, A. Tsianakas +9 more
2020Journal of the European Academy of Dermatology and Venereology101 citations Open access
Semantic Scholar
Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double‐blinded, controlled studies (UNCOVER‐1, UNCOVER‐2, UNCOVER‐3)
K. Papp, C. Leonardi, A. Blauvelt, K. Reich +9 more
2018British Journal of Dermatology90 citations Open access
Semantic Scholar
Ixekizumab treatment improves fingernail psoriasis in patients with moderate‐to‐severe psoriasis: results from the randomized, controlled and open‐label phases of UNCOVER‐3
P. V. D. van de Kerkhof, L. Guenther, A. Gottlieb, M. Sebastian +8 more
2017Journal of the European Academy of Dermatology and Venereology84 citations
Semantic Scholar
Treatment outcomes with ixekizumab in patients with moderate‐to‐severe psoriasis who have or have not received prior biological therapies: an integrated analysis of two Phase III randomized studies
A. Gottlieb, J. Lacour, N. Korman, S. Wilhelm +6 more
2016Journal of the European Academy of Dermatology and Venereology58 citations Open access
Semantic Scholar
Efficacy and safety of continuous every‐2‐week dosing of ixekizumab over 52 weeks in patients with moderate‐to‐severe plaque psoriasis in a randomized phase III trial (IXORA‐P)
R. Langley, K. Papp, M. Gooderham, L. Zhang +5 more
2018British Journal of Dermatology57 citations Open access
Semantic Scholar
The effect of bodyweight on the efficacy and safety of ixekizumab: results from an integrated database of three randomised, controlled Phase 3 studies of patients with moderate‐to‐severe plaque psoriasis
K. Reich, L. Puig, L. Mallbris, L. Zhang +2 more
2017Journal of the European Academy of Dermatology and Venereology41 citations
Semantic Scholar
Ixekizumab sustains high level of efficacy and favourable safety profile over 4 years in patients with moderate psoriasis: results from UNCOVER‐3 study
M. Lebwohl, K. Gordon, G. Gallo, L. Zhang +1 more
2019Journal of the European Academy of Dermatology and Venereology31 citations Open access
Semantic Scholar
Reaching complete or near‐complete resolution of psoriasis: benefit and risk considerations
A. Blauvelt, C. Griffiths, M. Lebwohl, U. Mrowietz +11 more
2017British Journal of Dermatology13 citations Open access
Semantic Scholar
398 Efficacy and safety of ixekizumab for the treatment of plaque psoriasis: Results through 108 weeks randomised, phase III clinical trial (UNCOVER-3)
A. Blauvelt, M. Gooderham, L. Iversen, S. Ball +4 more
20175 citations Open access
Semantic Scholar
An indirect comparison of long‐term efficacy of every‐2‐week dosing vs. recommended dosing of ixekizumab in patients who had static Physician's Global Assessment > 1 at week 12
K. Papp, C. Maari, A. Cauthen, Melinda J. Gooderham +6 more
2020British Journal of Dermatology4 citations
Semantic Scholar
Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double‐blinded, controlled studies (UNCOVER‐1, UNCOVER‐2, UNCOVER‐3)
K. Papp, C. Leonardi, A. Blauvelt, K. Reich +9 more
20184 citations
Semantic Scholar
Long-term efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis sustained for three years: Results of a randomized controlled phase 3 study (UNCOVER-3)
C. Leonardi, C. Maari, S. Philipp, J. Crowley +4 more
2018Journal of American Academy of Dermatology0 citations
Semantic Scholar
伊赛珠单抗对银屑病的治疗:三项双盲对照研究的综合药效分析(发现‐1、发现‐2、发现‐3)
K. Papp, C. Leonardi, A. Blauvelt, K. Reich +9 more
20180 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Ball×6
Invite
S. Ball — researcher profile on SciRah
L. Mallbris×6
Invite
L. Mallbris — researcher profile on SciRah
K. Papp×5
Invite
K. Papp — researcher profile on SciRah
A. Blauvelt×5
Invite
A. Blauvelt — researcher profile on SciRah

×5

Invite

K. Reich — researcher profile on SciRah

Invite

J. Erickson — researcher profile on SciRah

Invite

N. Korman — researcher profile on SciRah

Invite

A. Morita — researcher profile on SciRah

Invite

C. Paul — researcher profile on SciRah

Invite

A. Gottlieb — researcher profile on SciRah

Invite

P. Foley — researcher profile on SciRah

M. Gooderham×2

Invite

M. Gooderham — researcher profile on SciRah